Tong-Yoon Kim (Tong Yoon Kim)
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 8
Publications (10 Years): 8
Publications
- Ari Ahn, Hoon Seok Kim, Tong-Yoon Kim, Jong-Mi Lee, Dain Kang, Haein Yu, Chae Yeon Lee, Yonggoo Kim, Ki-Seong Eom, Myung-Shin Kim
- Ari Ahn, Hoon Seok Kim, Tong-Yoon Kim, Jong-Mi Lee, Dain Kang, Haein Yu, Chae Yeon Lee, Yonggoo Kim, Ki-Seong Eom, Myung-Shin Kim
- Ari Ahn, Hoon Seok Kim, Tong-Yoon Kim, Jong-Mi Lee, Dain Kang, Haein Yu, Chae Yeon Lee, Yonggoo Kim, Ki-Seong Eom, Myung-Shin Kim
- Ari Ahn, Hoon Seok Kim, Tong-Yoon Kim, Jong-Mi Lee, Dain Kang, Haein Yu, Chae Yeon Lee, Yonggoo Kim, Ki-Seong Eom, Myung-Shin Kim
- Tong-Yoon Kim, JunHui Lee, Young-Woo Jeon
- Tong-Yoon Kim, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung Soo Park, Silvia Park, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hawn Shin, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Jong-Mi Lee, Myung-Shin Kim, Sung-Eun Lee
- Tong-Yoon Kim, Silvia Park, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung Soo Park, Young-Woo Jeon, Seung-Hawn Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je KimDepth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers 14 (13) (2022)